as03-adjuvanted h1n1 pandemic influenza vaccine
Influenza A Virus, H1N1 Subtype
University Health Network, TorontovaccinePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Influenza A Virus, H1N1 Subtype cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
non-adjuvanted A(H1N1) influenza vaccine Chiltern Pesquisa Clinica Ltda | Phase 3 | BB |
Adjuvanted A Influenza Vaccine Chiltern Pesquisa Clinica Ltda | Phase 3 | BB |
Same molecule, other indications
as03-adjuvanted h1n1 pandemic influenza vaccine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →